Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History XBIT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics XBIT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 15.07.2021

XBiotech Inc

XBIT
Current price
3.00 USD +0.02 USD (+0.67%)
Last closed 2.75 USD
ISIN CA98400H1029
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 90 853 344 USD
Yield for 12 month -55.22 %
1Y
3Y
5Y
10Y
15Y
XBIT
21.11.2021 - 28.11.2021

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas. Address: 5217 Winnebago Lane, Austin, TX, United States, 78744

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18.00 USD

P/E Ratio

Dividend Yield

Financials XBIT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures XBIT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

+300 000 USD

Current Quarter

+867 000 USD

Last Quarter

Current Year

Last Year

-1 744 000 USD

Current Quarter

+867 000 USD

Last Quarter

EBITDA -43 413 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -13.78 %
PEG Ratio
Return On Equity TTM -20.53 %
Wall Street Target Price 18.00 USD
Revenue TTM 300 000 USD
Book Value 5.73 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -93.30 %
Dividend Yield
Gross Profit TTM 3 359 000 USD
Earnings per share -1.29 USD
Diluted Eps TTM -1.29 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation XBIT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 24.05
Price Sales TTM 12.23
Enterprise Value EBITDA -1.60
Price Book MRQ 0.52

Technical Indicators XBIT

For 52 Weeks

2.50 USD 8.32 USD
50 Day MA 2.88 USD
Shares Short Prior Month 995 993
200 Day MA 4.43 USD
Short Ratio 22.82
Shares Short 534 022
Short Percent 5.03 %